Emagix Inc

Emagix Inc. has developed a software platform that analyzes images from fluorescein angiography (FA) tests to generate a composite image, providing new insights for ophthalmologists to detect diabetic retinopathy at a much earlier stage than with the results from FA tests alone.

Operating in prime, Emagix Inc operates.

As a business in prime, Emagix Inc is listed here with the public details available about it.

Directory data places it at the Creative Destruction Lab alumni company stage.

Website: emagix.ca/the-team